DK121122B - Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater. - Google Patents

Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater.

Info

Publication number
DK121122B
DK121122B DK541264AA DK541264A DK121122B DK 121122 B DK121122 B DK 121122B DK 541264A A DK541264A A DK 541264AA DK 541264 A DK541264 A DK 541264A DK 121122 B DK121122 B DK 121122B
Authority
DK
Denmark
Prior art keywords
betaines
pure
preparation
cephalosporin derivatives
cephalosporin
Prior art date
Application number
DK541264AA
Other languages
English (en)
Inventor
S Eardley
G Stocker
A Long
C Sharp
P Wilkinson
H Crisp
J Oughton
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK121122B publication Critical patent/DK121122B/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J11/00—Devices or arrangements  of selective printing mechanisms, e.g. ink-jet printers or thermal printers, for supporting or handling copy material in sheet or web form
    • B41J11/26—Pin feeds
    • B41J11/32—Adjustment of pin wheels or traction elements, e.g. laterally
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41L—APPARATUS OR DEVICES FOR MANIFOLDING, DUPLICATING OR PRINTING FOR OFFICE OR OTHER COMMERCIAL PURPOSES; ADDRESSING MACHINES OR LIKE SERIES-PRINTING MACHINES
    • B41L5/00—Autographic registers or like manifolding apparatus using movable strips or webs
    • B41L5/04—Autographic registers or like manifolding apparatus using movable strips or webs with mechanisms for feeding webs or for arranging web feed; with web storage arrangements
    • B41L5/06—Autographic registers or like manifolding apparatus using movable strips or webs with mechanisms for feeding webs or for arranging web feed; with web storage arrangements by means of rollers, wheels, or chains, e.g. with pins transversely
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T403/00—Joints and connections
    • Y10T403/59—Manually releaseable latch type
    • Y10T403/599—Spring biased manipulator
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/20—Control lever and linkage systems
    • Y10T74/20576—Elements
    • Y10T74/20636—Detents
    • Y10T74/2066—Friction

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Handling Of Sheets (AREA)
DK541264AA 1963-11-04 1964-11-03 Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater. DK121122B (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB43441/63A GB1101561A (en) 1963-11-04 1963-11-04 Cephalosporin betaines
GB4731663 1963-12-02
GB2885764 1964-07-13

Publications (1)

Publication Number Publication Date
DK121122B true DK121122B (da) 1971-09-13

Family

ID=27258760

Family Applications (3)

Application Number Title Priority Date Filing Date
DK541264AA DK121122B (da) 1963-11-04 1964-11-03 Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater.
DK603469AA DK124758B (da) 1963-11-04 1969-11-14 Fremgangsmåde til fremstilling af en cephalosporinforbindelse i form af et syreadditionssalt af et betain.
DK63371AA DK126205B (da) 1963-11-04 1971-02-12 Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK603469AA DK124758B (da) 1963-11-04 1969-11-14 Fremgangsmåde til fremstilling af en cephalosporinforbindelse i form af et syreadditionssalt af et betain.
DK63371AA DK126205B (da) 1963-11-04 1971-02-12 Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater.

Country Status (14)

Country Link
US (2) US3280118A (da)
JP (1) JPS5021530B1 (da)
BE (2) BE641338A (da)
CH (2) CH462171A (da)
CY (1) CY555A (da)
DE (2) DE1795609A1 (da)
DK (3) DK121122B (da)
FR (5) FR1384197A (da)
GB (3) GB1101561A (da)
IL (2) IL26882A (da)
MY (1) MY7000168A (da)
NL (3) NL6412804A (da)
NO (1) NO133805C (da)
SE (2) SE318277B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3422099A (en) * 1966-02-18 1969-01-14 Bristol Myers Co 7-(alpha-hydroxy-(2' or 3'-thienyl)-acetamido) cephalosporanic acids and related salts and derivatives
US3391141A (en) * 1966-07-07 1968-07-02 Bristol Myers Co Synthetic cephalosporins
US3498979A (en) * 1967-04-03 1970-03-03 Glaxo Lab Ltd Recovery of n-(7-2'-thienylacetamidoceph-3-em-3-ylmethyl) pyridinium - 4-carboxylate from an acid addition salt thereof
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins
US4198504A (en) * 1978-11-02 1980-04-15 Bristol-Myers Company [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives
FR2457295A1 (fr) * 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4665168A (en) * 1986-04-14 1987-05-12 Eli Lilly And Company Cephalosporin intermediate
US4734408A (en) * 1986-12-17 1988-03-29 Eli Lilly And Company Crystalline cephalosporin antibiotic salts and solvates
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
GB2270054A (en) * 1992-08-29 1994-03-02 Gen Motors France Snap-fit steering column connection with lash adjuster.
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
US11582066B2 (en) 2019-12-19 2023-02-14 Cisco Technology, Inc. Techniques for extending a cellular quality of service bearer through an enterprise fabric

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218318A (en) * 1962-08-31 1965-11-16 Lilly Co Eli 7-heterocyclic-substituted-acylamido cephalosporins
US3226384A (en) * 1963-01-25 1965-12-28 Nat Res Dev Cephalosporin ca derivatives
US3225038A (en) * 1963-06-05 1965-12-21 Lilly Co Eli Benzyl substituted-pyridinomethyl cephalosporins

Also Published As

Publication number Publication date
DE1795581B2 (de) 1977-12-29
SE318278B (da) 1969-12-08
US3313176A (en) 1967-04-11
GB1101562A (en) 1968-01-31
FR1481034A (fr) 1967-05-19
US3280118A (en) 1966-10-18
DE1795581A1 (de) 1972-04-27
DK126205B (da) 1973-06-18
DE1795581C3 (de) 1978-09-07
DK124758B (da) 1972-11-20
GB1052068A (da)
NL6412804A (da) 1965-05-06
CH471078A (de) 1969-04-15
NL148060B (nl) 1975-12-15
NL6909298A (da) 1969-08-25
CH462171A (de) 1968-09-15
BE641338A (da) 1964-04-16
GB1101561A (en) 1968-01-31
FR4011M (da) 1966-03-21
DE1795609A1 (de) 1972-04-27
NO133805C (da) 1976-06-30
DE1445844A1 (de) 1969-01-16
MY7000168A (en) 1970-12-31
FR116F (da)
IL22384A (en) 1968-04-25
IL26882A (en) 1968-04-25
DE1795610A1 (de) 1972-04-27
NL7014054A (en) 1971-01-25
NO133805B (da) 1976-03-22
FR1384197A (fr) 1965-01-04
CY555A (en) 1970-08-18
SE318277B (da) 1969-12-08
FR1414624A (fr) 1965-10-15
DE1795610B2 (de) 1975-08-28
BE655273A (da) 1965-05-04
JPS5021530B1 (da) 1975-07-23

Similar Documents

Publication Publication Date Title
DK117953B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK121122B (da) Fremgangsmåde til fremstilling af rene betainer af cephalosporinderivater.
DK112032B (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy- eller -acyloxy-Δ<4>-estrenderivater.
DK120544C (da) Fremgangsmåde til fremstilling af cephalosporinderivater.
DK116292B (da) Fremgangsmåde til fremstilling af phenylalkanolaminderivater.
DK119457B (da) Analogifremgangsmåde til fremstilling af hovedsagelig rene transisomere af p-aminoalkoksyfenylalkener.
DK107806C (da) Fremgangsmåde til fremstilling af hydrazonderivater af diphenylmethyl-1-aminopiperidiner.
DK114697B (da) Fremgangsmåde til fremstilling af 25-desacetylderivater af rifamyciner.
DK116443B (da) Fremgangsmåde til fremstilling af 3-amino-N-carbamylpyrazolderivater.
DK112321B (da) Fremgangsmåde til fremstilling af 2-methyl-2-alkenyl-chromanderivater.
DK122761B (da) Analogifremgangsmåde til fremstilling af arylsulfonylurinstofderivater.
DK104629C (da) Fremgangsmåde til fremstilling af 7-oxodesacetamidocolchicinderivater.
DK119555B (da) Fremgangsmåde til fremstilling af 37β-hydroxy-Δ<4>-androsten- eller -ostrenderivater.
DK122458B (da) Fremgangsmåde til fremstilling af nitrofurylalkenylenpyridinderivater.
DK119157B (da) Fremgangsmåde til fremstilling af 17α-acyl-16α-hydroxy-pregnen-derivater.
DK104680C (da) Fremgangsmåde til fremstilling af derivater af 6-methyl-8-aminomethyl-ergolin I.
DK120239B (da) Fremgangsmåde til fremstilling af piperazin-fenylætanolderivater.
DK105161C (da) Fremgangsmåde til fremstilling af 3α-phenylgranatanderivater.
DK102920C (da) Fremgangsmåde til fremstilling af 1-cyancolchicinderivater.
DK119608B (da) Fremgangsmåde til fremstilling af dibenzocycloheptenderivater.
DK123024B (da) Fremgangsmåde til fremstilling af derivater af L-lysin.
DK104681C (da) Fremgangsmåde til fremstilling af 4-hydroxymethylcolchicinderivater.
DK112241B (da) Fremgangsmåde til fremstilling af pyrazinderivater.
DK108091C (da) Fremgangsmåde til fremstilling af pyrazolonderivater.
DK126381B (da) Fremgangsmåde til fremstilling af N-halogenalkyl-5-nitroimidazolderivater.